StockCIK 879407
ARROWHEAD PHARMACEUTICALS, INC. (ARWR): Insider Trades and Fund Holdings
In the past 12 months, ARROWHEAD PHARMACEUTICALS, INC. insiders reported 0 open-market purchases worth $0 and 2 sales worth $1.19M; 0 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$1.19MSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 20, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 20 | Michael S. PerryDirector | ▼ SELL | $1.01M |
| Aug 20 | Adeoye Y. OlukotunDirector | ▼ SELL | $174K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Michael S. Perry | Director | 0 | $0 | 1 | $1.01M |
| Adeoye Y. Olukotun | Director | 0 | $0 | 1 | $174K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report ARWR
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 468,921 | $38.2M | ▼ −54.8% |
| Bridgewater Associates | 0 | $0 | ▼ Sold out |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →